Skip to main content

Table 6 Correlation of SALL4 and OCT4 expression with patients' survival time

From: Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC)

Markers

Adenocarcinoma

Squamous cell carcinomas

(n = 77)

(n = 90)

Average survival months(cases)

P value

Average survival months(cases)

P value

SALL4

Negative

35.63 ± 3.18 (n = 51)

0.9866

36.98 ± 4.71 (n = 56)

0.3684

Positive

35.50 ± 6.85 (n = 26)

29.91 ± 6.23 (n = 34)

OCT4

Negative

38.73 ± 4.24 (n = 47)

0.1666

35.75 ± 4.54 (n = 67)

0.4815

Positive

30.38 ± 4.21 (n = 29)

30.13 ± 6.48 (n = 23)